Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 14, 2017; 23(14): 2539-2544
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2539
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2539
Table 1 Characteristics of Crohn’s disease patients by mean vitamin D level
| Mean < 30 (n = 115) | Mean ≥ 30 (n = 81) | |
| Age, (mean ± SD, yr) | 45.50 (15.07) | 54.26 (17.63) |
| DoD | 17.83 (11.77) | 22.58 (14.50) |
| Race | ||
| Caucasian | 66.96% | 87.65% |
| African-American | 31.30% | 12.35% |
| Others | 1.74% | 0.00% |
| Female | 61.74% | 71.6% |
| BMI | ||
| Low (< 18.5) | 11.30% | 8.64% |
| Normal (18.5-24.9) | 40.00% | 41.98% |
| Over Weight (25-29.9) | 20.00% | 27.16% |
| Obese (≥ 30) | 28.70% | 22.22% |
| Smoking | 26.96 | 11.11 |
| Steroids | 51.30 | 45.68 |
| Immune modulators | 84.35% | 76.54% |
| Biologicals | 61.74% | 51.85% |
| Thiopurines | 61.74% | 51.85% |
| Methotrexate | 20.87 | 13.58 |
- Citation: Venkata KVR, Arora SS, Xie FL, Malik TA. Impact of vitamin D on the hospitalization rate of Crohn's disease patients seen at a tertiary care center. World J Gastroenterol 2017; 23(14): 2539-2544
- URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2539.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i14.2539